ArticleFrontiers in immunology2018
Active Tuberculosis Is Characterized by Highly Differentiated Effector Memory Th1 Cells.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 34 citations in OpenAlex.
- CCR6 is essential for effective immunity againstInfection and immunity · 2026Article
- A multiplex Mtb-specific FluoroSpot assay measuring IFNγ, IL-2, and TNF-secreting cells can improve accuracy and differentiation across the tuberculosis spectrum.Journal of clinical microbiology · 2025Article
- Isoniazid preventive therapy modulates Mycobacterium tuberculosis-specific T-cell responses in individuals with latent tuberculosis and type 2 diabetes.Scientific reports · 2025Article
- Tuberculosis Vaccines and T Cell Immune Memory.Vaccines · 2024Review
- Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection.Nature communications · 2024Article
- HBHA induces IL-10 from CD4+ T cells in patients with active tuberculosis but IFN-γ and IL-17 from individuals withFrontiers in immunology · 2024Article
- When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.Frontiers in immunology · 2024Review
- Biological properties and diverse cytokine profiles followed by in vitro and in vivo infections with LSDV strain isolated in first outbreaks in Vietnam.Veterinary research communications · 2023Article
- Leukemic transformation during anti-tuberculosis treatment in aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: A case report and review of literature.World journal of clinical cases · 2023Article
- Immunogenicity and efficacy of an oral live-attenuated vaccine for bovine Johne's disease.Frontiers in immunology · 2023Article
- Plasma Levels of sFas-sFasL andBiomolecules · 2022Article
- Epidemiological and Cytokine Profile of Patients with Pulmonary and Extrapulmonary Tuberculosis in a Population of the Brazilian Amazon.Microorganisms · 2022Article
- Development of an Interferon-Gamma Release Assay (IGRA) to Aid Diagnosis of Histoplasmosis.Journal of clinical microbiology · 2022Article
- Evaluating the Performance of PPE44, HSPX, ESAT-6 and CFP-10 Factors in Tuberculosis Subunit Vaccines.Current microbiology · 2022Review
- In-Depth Immunophenotyping With Mass Cytometry During TB Treatment Reveals New T-Cell Subsets Associated With Culture Conversion.Frontiers in immunology · 2022Article
- Comparison of the frequency and phenotypic profile ofFrontiers in immunology · 2022Article
- Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease.Nature immunology · 2021Observational
- Classical CD4 T cells as the cornerstone of antimycobacterial immunity.Immunological reviews · 2021Review
- Monitoring Anti-tuberculosis Treatment Response Using Analysis of Whole BloodFrontiers in immunology · 2020Article
- A Framework of All Discovered Immunological Pathways and Their Roles for Four Specific Types of Pathogens and Hypersensitivities.Frontiers in immunology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 2 countries.
Riccardo ArrigucciPublic Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States.
Karim LakehalPublic Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States.
Pooja VirPublic Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States.
Deborah HandlerGlobal Tuberculosis Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States.
Amy L DavidowDepartment of Biostatistics, School of Public Health, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States.
Rosa HerreraFacultad de Medicina Mexicali, Universidad Autónoma de Baja California, Mexicali, Mexico.
Julia Dolores Estrada-GuzmánFacultad de Medicina Mexicali, Universidad Autónoma de Baja California, Mexicali, Mexico.
Yuri BushkinPublic Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States.
Sanjay TyagiPublic Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States.
Alfred A LardizabalGlobal Tuberculosis Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States.
Maria Laura GennaroPublic Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States.
Rutgers, The State University of New Jersey · USUniversidad Autónoma de Baja California · MXBiostat (United States) · US
Funding
FISH-Flow platform for host-based tuberculosis diagnosticsR01AI104615 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI GENNARO, MARIA LAURA · 2013 to 2017
$5.5MRapid Analysis of Single T Cell Immunity Signatures in TuberculosisR01AI106036 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI BUSHKIN, YURI, GENNARO, MARIA LAURA · 2012 to 2016
$3.8MNIAID NIH HHS R01 AI104615NIAID NIH HHS R01 AI106036
Abstract
Despite advances in diagnosing latent
Indexed as
AdultAgedCD4-Positive T-LymphocytesCell DifferentiationCells, CulturedFemaleHumansImmunologic MemoryImmunologic TestsInterferon-gammaLatent TuberculosisMaleMiddle AgedMycobacterium tuberculosisTh1 CellsTuberculosisInterferon-gammaTumor Necrosis Factor-alphacytokineFISH-Flowflow cytometryimmunophenotypingmemory T cellssingle-cell gene expressionT cell activation
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.